Skip to main content
SpringerLink
Log in
Book cover

Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS pp 1005–1028Cite as

Dialyzers, Dialysates, and Water Treatment

  • Chapter

  • 302 Accesses

Abstract

Hemodialysis is a complex process performed with apparent simplicity. The major extracorporeal components of this therapy are dialyzers, dialysate, and water treatment systems. In this chapter, we will present a brief synopsis of dialyzers and their operative features and will discuss dialysate composition and water treatment systems.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ono T, Kataoka H, Kunimoto T: Quantitative analysis on the removal of b2-microglobulin from chronic dialysis patients. Blood Purif 4: 212–214, 1985.

    Google Scholar 

  2. Kuhle C, Fricke H, Weld E, Schifft H: High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. Am J Nephrol 16: 484–488, 1996.

    Article  Google Scholar 

  3. Mujais SK, and Ivanovich P: Membranes for extracorporeal therapy. In: Replacement of Renal Function by Dialysis. J Matier, editor, 3rd edition 1989.

    Google Scholar 

  4. Gohl H, Konstantin P: Membrane and filters for hemofiltration. In: LW Henderson, EA Quellhorst, CA Baldamus, MJ Lysaght, eds, Hemofiltration. Springer-Verlag, Berlin, p 41, 1986.

    Google Scholar 

  5. Leypoldt JK, Frigon RP, Henderson LW: Macromolecular charge affects hemofilter solute sieving. Trans Am Soc Artif Intern Organs 32: 384–387, 1986.

    CAS  Google Scholar 

  6. Konstantin P, Bailey RM: Polycarbonate-polyether (PC-PE) flat sheet membrane: manufacture, structure and performance. Blood Purif 4: 6–12, 1985.

    Article  Google Scholar 

  7. Gohl H, Raff M, Harttig D, Deppisch R: PC-PE hollow-fiber membrane structure, performance characteristics, and manufacturing. Blood Purif 4: 23–31, 1985.

    Google Scholar 

  8. Akizawa T, Kitaoka T, Koshikawa S, Watanabe T, Imamura K, Tsurumi T, Suma Y, Eiga S: Development of a regenerated cellulose non-complement activating membrane for hemodialysis. Trans Am Soc Artif Intern Organs 32: 76–84, 1986.

    CAS  Google Scholar 

  9. Hildebrand U, Quellhorst E: Influence of various membranes on the coagulation system during dialysis. Contrib Nephrol 46: 92–101, 1985.

    PubMed  CAS  Google Scholar 

  10. Van Stone JC: Hemodialysis apparatus. In: JT Daugirdas, TS Ing, Handbook of Dialysis, 2nd ed, Little, Brown, Boston, p 29, 1988.

    Google Scholar 

  11. Kaufman AM, Frinak S, Godmere RO, Levin NW: Clinical experience with heat sterilization for reprocessing dialyzers. ASAIO J 38: M338 - M340, 1992.

    Article  PubMed  CAS  Google Scholar 

  12. Sigdell Jan Erik: Operating characteristics of hollow-fiber dialyzers. In: AR Nissenson, RN Fine, DE Gentile, eds, Clinical Dialysis, 2nd ed. Appleton and Lange, San Mateo, CA, pp 106–107, 1990.

    Google Scholar 

  13. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44: 484–494, 1993.

    Article  PubMed  CAS  Google Scholar 

  14. Arnout MA, Hakim RM, Todd RF, Dana N, Colten HR: Increased expression of an adhesion promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 312: 457–462, 1985.

    Article  Google Scholar 

  15. Dinarello CA: Cytokines and biocompatibility. Blood Purif 8: 208–213, 1990.

    Article  PubMed  CAS  Google Scholar 

  16. Strasser T, Schiffi H: Generation of leukotriene B4 by hemodialyzer membranes: a novel index of biocompatibility. Klin Wochenschr 69: 808–812, 1991.

    Article  PubMed  CAS  Google Scholar 

  17. Craddock PR, Fehr J, Delmasso AP, Brigham KL, Jacob HS: Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59: 878–888, 1977.

    Article  Google Scholar 

  18. Rault RB, Silver MR: Severe reactions during hemodialysis. Am J Kidney Dis 5: 128–135, 1985.

    PubMed  CAS  Google Scholar 

  19. Walker JF, Lindsay RM, Peters SD, Sibbalb WJ, Linton AL: A sheep model to examine the cardiopulmonary maniestations of blood dialyzer interactions. Am Soc Artif Intern Organs 6: 123–130, 1983.

    Google Scholar 

  20. Hakim RM, Breillatt J, Lazarus JM, Port FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311: 878–882, 1984.

    Article  PubMed  CAS  Google Scholar 

  21. Daugirdas JT, Ing TS: First use reactions during hemodialysis: a definition of subtypes. Kidney Int 33 (Suppl 24): 537 - S43, 1988.

    Google Scholar 

  22. Pegues DA, Beck-Sague CM, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino MJ, Favero MS, Mackow RC, Jarvis WR: Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 42: 1232–1237, 1992.

    Article  PubMed  CAS  Google Scholar 

  23. Hakim RM, Fearon DT, Lazarus JM: Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 26: 194–210, 1984.

    Article  PubMed  CAS  Google Scholar 

  24. Himmelfarb J, Lazarus M, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 3: 271–276, 1991.

    Google Scholar 

  25. Arora N, Lambrou FH, Stewart MW, Vidrine-Parks L, Sandroni S: Sudden blindness associated with central nervous symptoms in a hemodialysis patient. Nephron 59: 490492, 1991.

    Google Scholar 

  26. Davenport A, Williams Ai: The effect of dialyzer reuse on peak expiratory flow rate. Respir Med 84: 17–21, 1990.

    Article  PubMed  CAS  Google Scholar 

  27. Stone WJ, Hakim RM: b2m amyloidosis in long-term hemodialysis patients. Am J Nephrol 9: 177–183, 1989.

    Article  PubMed  CAS  Google Scholar 

  28. Brunner FP, Brynger H, Ehrich JHH: Case control study on dialysis arthropathy: the influence of two different dialysis membranes:data from the EDTA registry. Nephrol Dial Transplant 5: 432–436, 1990.

    Article  PubMed  CAS  Google Scholar 

  29. van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J: Effect of dialysis membrane and patient’s age on signs of dialysis-related amyloidosis. Kidney Int 39: 1012 1019, 1991.

    Google Scholar 

  30. Chanard J, Bindi P, Lavand S: Carpal tunnel syndrome and type of dialysis membrane. Br J Med 298: 867–868, 1989.

    Article  CAS  Google Scholar 

  31. Jahn B, Betz M, Deppisch R, Janssen O, Hansch GM, Ritz E: Stimulation of b2m synthesis in lymphocytes after exposure to cuprophane dialyzer membranes. Kidney Int 405: 285–290, 1991.

    Article  Google Scholar 

  32. Lemke RP, Hample H, Lobech H: Lysine-specific cleavage of b2-m in amyloid deposits associated with hemodialysis. Kidney Int 36: 675–681, 1989.

    Article  Google Scholar 

  33. DiRaimondo CR, Pollak VE: b2m kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse. Am J Kidney Dis 5: 390–395, 1989.

    Google Scholar 

  34. Conger JD: Does hemodialysis delay recovery from acute renal failure? Semin Dial 3: 146–148, 1990.

    Article  Google Scholar 

  35. Solez K, Morel-Moroger L, Sraer JD: The morphology of “acute tubular necrosis in man.” Medicine (Baltimore) 58: 362–376, 1979.

    CAS  Google Scholar 

  36. Badr KF, Schreiner GF, Wasserman M, Ichikawa I: Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist. J Clin Invest 81: 1702–1709, 1988.

    Article  PubMed  CAS  Google Scholar 

  37. Linas SL, Whittenburg D, Parsons P, Repine JE: Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int 42: 610–616, 1992.

    Article  PubMed  CAS  Google Scholar 

  38. Schulman G, Fogo A, Gung A, Badr K, Hakim R: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 40: 1069–1074, 1991.

    Article  PubMed  CAS  Google Scholar 

  39. Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 3: 1227–1237, 1993.

    Google Scholar 

  40. Zaoui P, Hakim RM: Natural killer cell function in hemodialysis patients: effect of the dialysis membrane. Kidney Int 43: 1298–1305, 1993.

    Article  PubMed  CAS  Google Scholar 

  41. Degiannis D, Czarnecki M, Donati D: Normal T lymphocyte function in patients with end stage renal disease hemodialyzed with polysulfone membranes. Am J Nephrol 10: 276–282, 1990.

    Article  PubMed  CAS  Google Scholar 

  42. Donati D, Degiannis D, Coates N, Raskova J, Raska K Jr: Mixed lymphocyte reaction-induced release of soluble IL-2 receptor. Transplantation 51: 518–523, 1991.

    Article  Google Scholar 

  43. Guiterrez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 38: 487–494, 1990.

    Article  Google Scholar 

  44. Guiterrez A, Alvestrand A, Bergstrom J: Membrane selection and muscle protein catabolism. Kidney Int 42: S86 — S90, 1992.

    Google Scholar 

  45. Lindsay RM, Spanner EA, Heidenheim P, Kortas C, Blake PG: PCR, Kt/V and membrane. Kidney Int 43 (Suppl 41): 5268–5273, 1993.

    Google Scholar 

  46. Chanard J, Brunois JP, Melin JP, Lavaud S, Toupance O: Long term results of dialysis therapy with a highly permeable membrane. Artif Organs 6: 262–266, 1982.

    Google Scholar 

  47. Van Stone JC: Hemodialysis apparatus. In: JT Daugirdas, TS Ing, ed, Handbook of Dialysis, 3rd ed. Little, Brown, Boston, p 29, 1993.

    Google Scholar 

  48. Mendelssohn S, Swartz CD, Yudis M, Onesti G, Ramirez O, Brest AN: High glucose concentration dialysate in chronic hemodialysis. Trans ASAIO 13: 249–253, 1967.

    Google Scholar 

  49. Rosborough DC, Van Stone JC: Dialysate glucose. Semin Dial 6: 260–263, 1993.

    Article  Google Scholar 

  50. Ward RA, Wathen RL, Williams TE, Harding GB: Hemodialysate composition and intradialytic metabolic, acid—base, and potassium changes. Kidney Int 32: 129–35, 1987.

    Article  PubMed  CAS  Google Scholar 

  51. Wathen RA, Keshairah P, Hommeyer P, Cadwell K, Comty CM: The metabolic effects of hemodialysis with and without glucose in the dialysate. Am J Clin Nutr 31: 1870–1875, 1978.

    PubMed  CAS  Google Scholar 

  52. Grajower MM, Walter L, Albin J: Hypoglycemia in chronic hemodialysis patients: association with progranolol use. Nephron 26: 126–129, 1980.

    Article  PubMed  CAS  Google Scholar 

  53. Uraemic hypoglycaemia. Lancet 1: 660–661, 1986.

    Google Scholar 

  54. Ganda OP, Aoki TT, Soeldner JS, Morrison RS, Cahill GF Jr: Hormone-fuel concentrations in anephric subjects: effects of hemodialysis (with special reference to amino acids). J Clin Invest 57: 1403–1411, 1976.

    CAS  Google Scholar 

  55. Koppel JD, Swendseid ME, Shinaberger JH, Umezawa CY: The free and bound amino acids removed by hemodialysis. Trans ASAIO 19: 309–303, 1973.

    Article  Google Scholar 

  56. Ward RA, Shirlow MJ, Hayes JM, Chapman GV, Farrel PC: Protein catabolism during hemodialysis. Am J Clin Nutr 32: 2443–2449, 1979.

    PubMed  CAS  Google Scholar 

  57. Hubner W, Sieberth HG, Diemer A, Finke K, Prange E: Effects of regular hemodialysis with glucose and glucose free dialysate on hyperlipemia. Proc EDTA 8: 174–181, 1971.

    Google Scholar 

  58. Ramirez G, Butcher DE, Morrison AO: Glucose concentration in the dialysate and lipid abnormalities in chronic hemodialysis patients. Int J Artif Organs 10: 31–36, 1987.

    PubMed  CAS  Google Scholar 

  59. Ramirez G, Bercaw BL, Butcher DE, Mathis HL, Brueggemeyer C, Newton JL: The role of glucose in hemodialysis: the effect of glucose free dialysate. Am J Kidney Dis 7: 413–420, 1986.

    PubMed  CAS  Google Scholar 

  60. Daugirdas JT: Dialysis hypotension: a hemodynamic analysis. Kidney Int 39: 233–246, 1991.

    Article  PubMed  CAS  Google Scholar 

  61. de Vries PM: Plasma volume changes during hemodialysis. Semin Dial 5: 42–47, 1992.

    Article  Google Scholar 

  62. Sherman RA: The pathophysiologic basis for hemodialysisrelated hypotension. Semin Dial 1: 136–142, 1988.

    Article  Google Scholar 

  63. Palmer BF: The effect of dialysate composition on systemic hemodynamics. Semin Dialy 5: 54–60, 1992.

    Article  Google Scholar 

  64. Kinet JP, Soyeur D, Ballard N, Saint-Remy M, Collilgnon P, Godon J-P: Hemodynamic study of hypotension during hemodialysis. Kidney Int 21: 868–876, 1982.

    Article  PubMed  CAS  Google Scholar 

  65. Rouby JJ, Rottembourg J, Durande JP, Basset JY, Doogoulet P, Glaser P, Legrain M: Hemodynamic changes induced by regular hemodialysis and sequential ultrafiltration hemodialysis: a comparative study. Kidney Int 17: 808810, 1980.

    Google Scholar 

  66. Wehle B, Asaba H, Castenfors J, Furst P, Gunnaroson B, Shaldon S, Bergstrom J: Hemodynamic changes during sequential ultrafiltration and dialysis. Kidney Int 15: 411–418, 1979.

    Article  PubMed  CAS  Google Scholar 

  67. Baldamus CA, Ernst W, Frei U, Koch KM: Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. Nephron 31: 324–332, 1982.

    Article  PubMed  CAS  Google Scholar 

  68. Petitclerc T, Drueke T, Man N, Funck-Brentano JL: Cardiovascular stability on hemodialysis. Adv Nephrol 16: 351–370, 1987.

    CAS  Google Scholar 

  69. Raja R, Henriquez M, Kramer M, Rosenbaum JL: Intradialytic hypotension—role of osmolar changes and acetate influx. Artif Organs 9: 17–21, 1985.

    Article  Google Scholar 

  70. Henrich WL, Woodard TD, Blachley JD, Gomez-Sanches C, Pettinger W, Cronin RE: Role of osmolality in blood pressure stability after dialysis and ultrafiltration. Kidney Int 18: 480–488, 1980.

    Article  PubMed  CAS  Google Scholar 

  71. Dumler F, Grondin G, Levin NW: Sequential high/low sodium hemodialysis: an alternative to ultrafiltration. Trans ASAIO 25: 351–353, 1979.

    Article  CAS  Google Scholar 

  72. Daugirdas JT, Al-Kudsi RR, Ing TS, Norusis MJ: A double-blind evaluation of sodium gradient hemodialysis. Am J Nephrol 5: 163–168, 1985.

    Article  PubMed  CAS  Google Scholar 

  73. Raja R, Kramer M, Barber K, Chen S: Sequential changes in dialysate sodium (DNa) during hemodialysis. Trans ASAIO 24: 649–651, 1983.

    Google Scholar 

  74. Bedichek E, Kirschbaum B, Sica D: Comparison of the hemodynamic and hormonal effects of hemodialysis using programmable vs constant sodium dialysate (abstract). J Am Soc Nephrol 3: 354, 1992.

    Google Scholar 

  75. Heineken FS, Evans MC, Keen ML: Intercompartmental fluid shifts in hemodialysis patients. Biotechnol Prog 3: 69, 1987.

    Article  Google Scholar 

  76. Star RA, Hootkins R, Thompson JR, Pool T, Toto RD: Variability and stability of two pool urea mass transfer coefficient (abstract). J Am Soc Nephrol 3: 395, 1992.

    Google Scholar 

  77. Tokars JI, Alter MJ, Faverso MS: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: National surveillance of dialysis-associated diseases in the United States, 1992. USDHHS, 1992.

    Google Scholar 

  78. Leunissen KML, Hoorntje SJ, Fiers HA, Dekkers WT, Mulder AW: Acetate versus bicarbonate hemodialysis in critically ill patients. Nephron 42: 146–151, 1986.

    Article  PubMed  CAS  Google Scholar 

  79. Graefe U, Milutenovich J, Follette WC, Vizzo JE, Babb AL, Scribner BH: Less dialysis induced morbidity and vascular instability with bicarbonate in dialysate. Ann Intern Med 88: 332–336, 1978.

    Article  PubMed  CAS  Google Scholar 

  80. Vincent JL, Vanherweghem JL, Degante JP, Berre J, Dufaye P, Kahn RJ: Acetate induced myocardial depression during hemodialysis for acute renal failure. Kidney Int 22: 653–657, 1982.

    Article  PubMed  CAS  Google Scholar 

  81. Novello A, Kelsch RC, Easterling RE: Acetate intolerance during hemodialysis. Clin Nephrol 5: 29–32, 1976.

    PubMed  CAS  Google Scholar 

  82. Hakim RM, Ponzer M-A, Tilton D, Lazarus JM, Gottlieb MN: Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients. Kidney Int 28: 535–540, 1985.

    Article  PubMed  CAS  Google Scholar 

  83. Tolchin N, Roberts JL, Hayashi J, Lewis EJ: Metabolic consequences of high mass-transfer hemodialysis. Kidney Int 11: 306, 1977.

    Article  Google Scholar 

  84. Henrich WL: Hemodynamic instability during hemodialysis. Kidney Int 30: 605–612, 1986.

    Article  PubMed  CAS  Google Scholar 

  85. Lonnemann G, Bingel M, Koch KM, Shaldon S, Dinarello CA: Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lymphokine Res 6: 63–70, 1987.

    PubMed  CAS  Google Scholar 

  86. Garella S, Chang BS: Hemodialysis-associated hypoxemia. Am J Nephrol 4: 273–279, 1984.

    Article  PubMed  CAS  Google Scholar 

  87. Ross EA, Nissenson AR: Dialysis-associated hypoxemia: insights into pathophysiology and prevention. Semin Dial 1: 3339, 1988.

    Google Scholar 

  88. Wolff J, Pendersen T, Rossen M, Cleeman-Rasmussen K: Effects of acetate and bicarbonate dialysis on cardiac performance, transmural myocardial perfusion and acid–base balance. Int J Artif Organs 9: 105–110, 1986.

    PubMed  CAS  Google Scholar 

  89. Vaziri ND, Wilson A, Mukai D, Daruish R, Rutz A, Hyatt J, Moreno C: Dialysis hypoxemia—role for dialyzer membrane and dialysate delivery system. Am J Med 77: 828–833, 1984.

    Article  PubMed  CAS  Google Scholar 

  90. Henrich WL, Woodard TD, Meyer BD, Chappell TR, Rubin L: High sodium bicarbonate and acetate hemodialysis: double blind crossover comparison of hemodynamic and ventilatory effects. Kidney Int 24: 240–245, 1983.

    Article  PubMed  CAS  Google Scholar 

  91. Velez RL, Woodard TD, Henrich WL: Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction. Kidney Int 26: 59–65, 1984.

    Article  PubMed  CAS  Google Scholar 

  92. Mehta BR, Fischer D, Ahmad M, Dubose TD: Effects of acetate and bicarbonate hemodialysis on cardiac function in chronic dialysis patients. Kidney Int 24: 782–787, 1983.

    Article  PubMed  CAS  Google Scholar 

  93. Vinay P, Prud’homme M, Vinet B, Cournoyer G, Degouet P, Ceville M, Gougoux A, St-Louis G, Lapierre L, Piette Y: Acetate metabolism and bicarbonate generation during hemodialysis: 10 years of observation. Kidney Int 31: 1194 1204, 1987.

    Google Scholar 

  94. Feinfeld DA, Sherwood LM: Parathyroid hormone and 1,225(OH)3D3 in chronic renal failure. Kidney Int 33: 1049 1058, 1988.

    Google Scholar 

  95. Felsenfeld AJ, Rodriguez M, Dunlay R, Llach F: A comparison of parathyroid gland function in hemodialysis patients with different forms of renal osteodystrophy. Nephrol Dial Transplant 6: 244–251, 1991.

    Article  PubMed  CAS  Google Scholar 

  96. Wing AJ: Optimum calcium concentration of dialysis fluid for maintenance haemodialysis. Br Med J 4: 145, 1968.

    Article  PubMed  CAS  Google Scholar 

  97. Johnson WJ, Goldsmith RS, Beabout JW. Prevention and reversal of secondary hyperparathyroidism in patients maintained by hemodialysis. Am J Med 56: 827–830, 1974.

    Article  PubMed  CAS  Google Scholar 

  98. Maynard JC, Cruz C, Kleerekoper M, Levin NW: Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med 104: 358–361, 1986.

    Article  PubMed  CAS  Google Scholar 

  99. Sherman RA, Bialy GB, Gazinski B, Bernholc AS, Eisinger RP: The effect of dialysate calcium levels on blood pressure during hemodialysis. Am J Kidney Dis 8: 244–247, 1986.

    PubMed  CAS  Google Scholar 

  100. Feltner SK, Lang RM, Neumann A, Spencer KT, Bushinsky DA, Borow KM: Physiological mechanisms for calcium-induced changes in systemic arterial pressure in stable dialysis patients. Hypertension 13: 213–218, 1989.

    Article  Google Scholar 

  101. Henrich WL, Hunt JM, Nixon JV: Increased ionized calcium and left ventricular contractility during hemodialysis. N Engl J Med 310: 19–23, 1984.

    Article  PubMed  CAS  Google Scholar 

  102. Lang RB, Feltner SK, Neuman A, Bushinsky DA, Borow KM: Left ventricular contractility varies directly with blood ionized calcium. Ann Intern Med 108: 524–529, 1988.

    Article  PubMed  CAS  Google Scholar 

  103. Morton AR, Hercz G, Coburn JW: Control of hyperphosphatemia in chronic renal failure. Semin Dial 3: 219–223, 1990.

    Article  Google Scholar 

  104. Mai ML, Emmett M, Shelkh MS, et al.: Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 36: 690–6695, 1989.

    Article  PubMed  CAS  Google Scholar 

  105. Coburn JW: Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy. Kidney Int 38 (Suppl 29):S54-S-61, 1990.

    Google Scholar 

  106. Slatopolsky E, Weerts C, Lopez-Hilker S: Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 315: 157–161, 1986.

    Article  PubMed  CAS  Google Scholar 

  107. Slatopolsky E, Weerts C, Norwood K, et al.: Long-term effects of calcium carbonate and 2.5 mEq/L calcium dialysate on mineral metabolism. Kidney Int 36: 897–903, 1989.

    Article  PubMed  CAS  Google Scholar 

  108. Sawyer N, Noonan K, Altmann P, Marsh F, Cunningham J: High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: effective phosphate control and aluminum avoidance in hemodialysis patients. Nephrol Dial Transpl 4: 105–109, 1989.

    CAS  Google Scholar 

  109. Van der Merwe WM, Rodger RSC, Grant AC: Low calcium dialysate and high-dose oral calcetriol in the treatment of secondary hyperparathyroidism in haemodialysis patients. Nephrol Dial Transplant 5: 874–877, 1990.

    Article  PubMed  Google Scholar 

  110. Ketchersid TL, Van Stone JC: Dialysate potassium. Semin Dial 4: 46–51, 1991.

    Article  Google Scholar 

  111. Spital A, Sterns RH: Potassium homeostasis in dialysis patients. Semin Dial 1:14–20, 1988.

    Google Scholar 

  112. Sherman RA, Hwang ER, Bernholz AS, Eisinger RP: Variability in potassium removal by hemodialysis. Am J Nephrol 6: 284–288, 1986.

    Article  PubMed  CAS  Google Scholar 

  113. Feig PU, Shook A, Sterns RH: Effect of potassium removal during hemodialysis on the plasma potassium concentration. Nephron 27: 25–30, 1981.

    Article  PubMed  CAS  Google Scholar 

  114. Hou S, McElroy PA, Nootens J, Beach M: Safety and efficacy of low-potassium dialysate. Am J Kidney Dis 13: 137–143, 1989.

    PubMed  CAS  Google Scholar 

  115. Morgan AG, Burkinshaw L, Robinson PJA, Rosen SM: Potassium balance and acid-base changes in patients undergoing regular hemodialysis therapy. Br Med J L•779–783, 1970.

    Google Scholar 

  116. Morrison G, Michelson EL, Brown S, Morganroth J: Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17: 811–819, 1980.

    Article  PubMed  CAS  Google Scholar 

  117. Wiegand CF, Davin TD, Raij LF, Kjellstrand CM: Severe hypokalemia induced by hemodialysis. Arch Intern Med 141: 167–170, 1981.

    Article  PubMed  CAS  Google Scholar 

  118. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA: National surveillance of hemodialysis-associated diseases in the United States, 1990. Trans ASAIO 39: 71–80, 1993.

    CAS  Google Scholar 

  119. Alter MJ, Favero MS, Moyer LA, Bland LA: National surveillance of dialysis-associated diseases in the United States, 1989. Trans ASAIO 37: 97–109, 1991.

    CAS  Google Scholar 

  120. Dunea G, Mahurkas SD, Mamdani B, Smith EC: Role of aluminum in dialysis dementia. Ann Intern Med 88: 502–504, 1978.

    Article  PubMed  CAS  Google Scholar 

  121. Coburn JW, Norros KC, Sherrard DJ, Bia M, Dach F, Alfrey A, Slatopolsky E: Toxic effects of aluminum in end-stage renal disease: discussion of a case. Am J Kidney Dis 12: 17 1184, 1988.

    Google Scholar 

  122. Llach F, Felsenfeld AJ, Coleman MD, Keveney JJ Jr, Pederson JA, Medlock R: The natural course of dialysis osteomalacia. Kidney Int 29 (Suppl 18): S74 - S79, 1986.

    Google Scholar 

  123. Centers for Disease Control: Dialysis dementia from aluminum. Epidemic Investigation Report EPI 81–39–2, June 10, 1982. CDC, Atlanta, 1982.

    Google Scholar 

  124. Topple MA, Bland LA, Favero MS, Jarvis WR: Investigation of hemolytic anemia after chloramine exposure in a dialysis center (letter). Trans ASAIO 34: 1060, 1988.

    Google Scholar 

  125. Yawata Y, Kjillstrand C, Buselmeier T, Howe R, Jacob H: Hemolysis in dialyzed patients: tap water-induced red blood cell metabolic deficiency. Trans ASAIO 18: 301–304, 1992.

    Article  Google Scholar 

  126. Neilan BA, Ehlers SM, Kolpin CF, Eaton JW: Prevention of chloramine-induced hemolysis in dialyzed patients. Clin Nephrol 10: 105–108, 1978.

    PubMed  CAS  Google Scholar 

  127. Gordon SM, Drachman J, Bland LA, Reid MH, Favero M, Jarvis WR: Epidemic hypotension in a dialysis center caused by sodium azide. Kidney Int 37: 110–115, 1990.

    Article  PubMed  CAS  Google Scholar 

  128. Anderson R, Beard JH, Sorley D: Fluoride intoxication in a dialysis unit. Maryland MMWR 29: 134–136, 1980.

    Google Scholar 

  129. Lough J, Noonan R, Gagnon R, Kaye M: Effects of fluoride on bone in chronic renal failure. Arch Pathol 99: 484–487, 1975.

    PubMed  CAS  Google Scholar 

  130. National News. Dialysis patients in Chicago die from fluoride poisoning; FDA issues safety alert. Contemp Dial Nephrol (Nov): 10–11, 1993.

    Google Scholar 

  131. Freeman RM, Lawton RL, Chamberlain MA: Hard-water syndrome. N Engl J Med 276: 1113–1118, 1967.

    Article  PubMed  CAS  Google Scholar 

  132. Evans DB, Slapak M: Pancreatitis in the hard water syndrome. Br Med J 3: 748, 1975.

    Article  PubMed  CAS  Google Scholar 

  133. Carlson DJ, Shapiro FL: Methemoglobinemia from well water nitrates: a complication of home dialysis. Ann Intern Med 73: 757–759, 1970.

    Article  PubMed  CAS  Google Scholar 

  134. Manzler AD, Schreiner CW: Copper-induced acute hemolytic anemia. A new complication of hemodialysis. Ann Intern Med 73: 409–412, 1970.

    Article  PubMed  CAS  Google Scholar 

  135. Matter BJ, Pederson J, Psimenos G, Lindeman RD: Lethal copper intoxication in hemodialysis. Trans ASAIO 15: 309315, 1969.

    Google Scholar 

  136. Gallery EDM, Blomfield J, Dixon SR: Acute zinc toxicity in haemodialysis. Br Med J 4: 33, 1973.

    Article  Google Scholar 

  137. Centers for Disease Control. Formaldehyde intoxication associated with hemodialysis–California. Epidemic Investigation Report EPI 81–73–2, May 7, 1984. CDC, Atlanta, 1984.

    Google Scholar 

  138. Orringer EP, Mattem WD: Formaldehyde-induced hemolysis during chronic hemodialysis. N Engl J Med 294: 1416 1420, 1976.

    Google Scholar 

  139. Nickey WA, Chinitz VL, Kim KE, Onesti G, Swartz C: Hypernatremia from water softener and malfunction during home dialysis. JAMA 214: 915–916, 1976.

    Article  Google Scholar 

  140. Vlchek DL: Staying tuned in to the high-tech world. Part 3: Water treatment update. Dial Transplant 19: 119–124, 1990.

    Google Scholar 

  141. Vlchek DL: Monitoring a hemodialysis water treatment system. In: AAMI Standards and Recommended Practices. Vol. 3: Dialysis. American National Standards, Arlington, VA, pp 267–277, 1993.

    Google Scholar 

  142. Johnson WJ, Taves DR: Exposure to excessive fluoride during hemodialysis. Kidney Int 5: 451–454, 1974.

    Article  PubMed  CAS  Google Scholar 

  143. Association for the Advancement of Medical Instrumentation. In: AAMI Standards and Recommended Practices. Vol. 3: Dialysis. American National Standards, Arlington, VA, pp 1–332, 1993.

    Google Scholar 

  144. Favero MS, Petersen NJ, Carson LA, Bond WW, Hindman 418, 1986. SH: Gram negative water bacteria in hemodialysis systems. Health Lab Sci 12: 321–334, 1975.

    Google Scholar 

  145. Bland LA, Favero MS: Microbiologic aspects of hemodialysis systems. In: AAMI Standerds and Recommended Practices. Vol. 3: Dialysis. American National Standards, Arlington, VA, pp 257–265, 1993.

    Google Scholar 

  146. Carson LA, Bland LA, Cusick LB, Favero MS, Bolan GA, Reingold AL, Good RC: Prevalence of non-tuberculous my- cobacterial in water supplies of hemodialysis centers. Appl Environ Microbiol 54 (12): 3122–3125, 1988.

    PubMed  CAS  Google Scholar 

  147. Lowry P, Beck-Sague CM, Bland LE, Aguero SM, Ardiuno 175, 1988. MJ, Minuth AN, Murray RA, Swenson JM, Jarvis WR: My- cobacterium Chelones infections among patients receiving high-flux dialysis in a hemodialysis unit in California. J Infect Dis 161: 85–90, 1990.

    Google Scholar 

  148. Bolan G, Reingold AL, Carson LA, Silcox VA, Woodley CL, NJ, Favero MS, Good RC, Browne CV: Infestious with Mycobactrium Chelonei in patients receiving dialysis and us- ing processed hemodialyzers. J Infect Dis 152:1013–1019, Hayes PS, Hightower AW, McFarland L, Brown J, Peterson 1985.

    Google Scholar 

  149. Carson La, Petersen NJ, Favero MS, Aguero SM: Growth characteristics of Atypi cal mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol 36: 839–846, 1978.

    Google Scholar 

  150. Favero MS: Distinguishing between high-level disinfection, reprocessing, and sterilization. IN: AAMI, Reuse of Disposables: Implications for Quality Health Care and Cost Containment. Technical Assessment Report No. 6, Arling-ton, VA, pp 19–20, 1983.

    Google Scholar 

  151. Favero MS, Bland LA: Microbiologic principles applied to reprocessing hemodialyzers. In: N Deane, RJ Wineman, JA Bemis, eds, Guide to Reprocessing of Hemodialyzers. Martinus Nijhoff, Boston, pp 63–73, 1986.

    Chapter  Google Scholar 

  152. Gordon SM, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Favero MS, Jarvis WR: Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicar bonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 2: 1436–1444, 1992.

    PubMed  CAS  Google Scholar 

  153. Favero MS, Petersen NJ, Boyer KM, Carson LA, Bond WW: Microbial contamination of renal dialysis systems and associ-ated health risks. Trans ASAIO 20: 175–183, 1974.

    Google Scholar 

  154. Klein E, Pass T, Harding GB, Wright R, Millon C: Microbial and endotoxin contamination in water and dialysate in the central United States. Artif Organs 14: 85–94, 1990.

    Article  PubMed  CAS  Google Scholar 

  155. Bland LA, Ridgeway MR, Aguero SM, Carson LA, Favero MS: Potential bacteriologic and endotoxin hazards associ-ated with liquid bicarbonate concentrate. Trans ASAIO 33: 542–545, 1987.

    CAS  Google Scholar 

  156. Pegues DA, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Gordon SM, Favero MS, Jarvis WR: A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 2: 1002–1007, 1992.

    Google Scholar 

  157. Centers for Disease Control: Clusters of bacteremia and pyrogenic reactions in hemodialysis patients—Georgia. Epidemic Investigation Report EPI86–65–2, April 22, 1987.

    Google Scholar 

  158. Centers for Disease Control: Bacteremia associated with reuse of disposble hollow-fiber hemodialyzers. MMWR 35: 417

    Google Scholar 

  159. Centers for Disease Control: Pyrogenic reactions in patients undergoing high–flux hemodialysis—California. Epidemic In vestigation Report EPI 86–80–2, June 1, 1987. CDC, Atlanta,1987.

    Google Scholar 

  160. Alter MJ, Favero MS, Miller JK, Coleman Pi, Bland LA: Reuse of hemodialyzers. Results of nationwide surveillance for adverse effects. JAMA 260: 2073–2076, 1988.

    Article  PubMed  CAS  Google Scholar 

  161. Bland LA, Favero MS, Oxborrow GS, Agnero SM, Seavy BP, Danielson JW: Effect of chemical germicides on the integrity of hemodialyzer membranes. Trans ASAIO 34: 172–175, 1988.

    CAS  Google Scholar 

  162. Jenkins SR, Lin FUC, Lin RS, Israel I, Petersen NJ: Pyro genic reactions and pseudomonas bacteremias in a hemo dialysis center. Dial Transplant 16: 192–197, 1987.

    Google Scholar 

  163. Oberle MW, Favero MS, Carson LA, Medina MS, Ramirez Puente M, Perez-Figueroa S: Fatal endotoxemia in dialysis patients at a summer camp. Dial Transplant 9: 549–550, 1980.

    Google Scholar 

  164. Bolan G, Reingold AL, Carson LA, Silcox VA, Woodley CL, Hayes PS, Hightower AW, McFarland L, Brown J, Petersen NJ, Favero MS, Good RC, Browne CV: Infections with Mycobactreium chelonia in patients receiving dialysis and using processed hemodialyzers. J Infect Dis 152: 1013–1019, 1985.

    Article  PubMed  CAS  Google Scholar 

  165. Bland LA, Favero MS: Microbiologic and endotoxin consid erations in hemodialyzer reprocessing. In: AAMI Standards and Recommended Practices. Vol. 3: Dialysis. American Na tional Standards, Arlington, VA, pp 45–52, 1993.

    Google Scholar 

  166. Gazenfield-Grazit E, Eliabou HE: Endotoxin antibodies in patients on maintenance hemodialysis. Israel J Med Sci 5: 1032–1035, 1969.

    Google Scholar 

  167. Jones DM, Tobin BM, Harlow GR, Ralston Ai: Antibody production in patients on regular hemodialysis to organisms present in dialysate. Proc Eur Dial Transplant Assoc 9: 575–576, 1972.

    PubMed  CAS  Google Scholar 

  168. Hindman SH, Favero MS, Carson LA, Petersen NJ, Schonberger LB, Solanto JT: Pyrogenic reactions during haemodialysis caused by entramural endotoxin. Lancet 2: 732–734, 1975.

    Article  PubMed  CAS  Google Scholar 

  169. Raij L, Shapiro FL, Michael AF: Endotoxemia in febrile reactions during hemodialysis. Kidney Int 4: 57–60, 1973.

    Article  PubMed  CAS  Google Scholar 

  170. Passavanti G, Buongiorno E, De Fino G, Fumarola D, Coratelli P: The permeability of dialytic membranes to en dotoxins: clinical and experimental findings. Int J Artif Or gans 12: 505–508, 1989.

    CAS  Google Scholar 

  171. Dinarello CA: Interleukin-1 and its biologically related cytokines. Adv Immunol 44: 153–205, 1989.

    Article  PubMed  CAS  Google Scholar 

  172. Loppnon H, Brade H, Durbaum I, Dinarello CA, Kusumoto S, Rictschel ET, Flad HO: IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 142: 3229–3238, 1989.

    Google Scholar 

  173. Duff GW, Atkins E: The detection of endotoxin by in-vitro production of endogenous pyrogen: comparison with limulus amebocyte lysate gelation. J Immunol Methods 52: 323–331, 1982.

    Article  PubMed  CAS  Google Scholar 

  174. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA: Detection of endotoxin-like interleukin-1 inducing activity during in vitro dialysis. Kidney Int 33: 29–35, 1988.

    Article  PubMed  CAS  Google Scholar 

  175. Lonnemann G: Dialysate bacteriological quality and the per meability of dialyzer membranes to pyrogenes. Kidney Int 43 (Suppl 41): S195–S200, 1993.

    Google Scholar 

  176. Favero MS, Port FK, Bernick JJ: In vivo studies of dialysis related endotoxemia and bacteremia. Nephron 27: 307–312, 1981.

    Article  PubMed  Google Scholar 

  177. Klinkman H, Falkenhagen D, Smollich BP: Investigation of permeability of highly permeable polysulfone membranes for pyrogens. Contrib Nephrol 46: 174–183, 1985.

    Google Scholar 

  178. Bingel M, Lonnemann G, Sheldon S, Koch KM, Dinarello CA: Human interleukin-1 production during hemodialysis. Nephron 43: 161–163, 1986.

    Article  PubMed  CAS  Google Scholar 

  179. Lonnemann G, Endress S, Van Der Meer JWM, Cannon JG, Koch KM, Dinarello CA: Differences in the synthesis and kinetics of release of interleukin-la, interleukin-113, and tumor necrosis factor from human mononuclear cells. Eur J Immunol 19: 1531–1536, 1987.

    Article  Google Scholar 

  180. Hakim RM, Breillat J, Lazarus JM, Port FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311: 878–882, 1984.

    Article  PubMed  CAS  Google Scholar 

  181. Cavallon J-M, Fitting C, Haeffner-Cavaillon N: Recombinant C5a enhances interleukin-1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol 20: 253–257, 1990.

    Article  Google Scholar 

  182. Schindler R, Gelfand JA, Dinarello CA: Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76: 1631–1638, 1990.

    PubMed  CAS  Google Scholar 

  183. Urena P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drucke T: Permeability of cellulosic and non-cellulosic membranes to endotoxins subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant 7: 16–28, 1992.

    PubMed  CAS  Google Scholar 

  184. Heberlin A, Urena P, Man NK, Drueke T, Descamp-Latscha B: In vitro studies of endotoxin transfer across cellulosic and non-cellulosic dialysis membranes. Part II. Interleukin-1 production. Contrib Nephrol 74: 79–85, 1989.

    Google Scholar 

  185. Dinarello CA, Koch KM, Shaldon S: Interleukin 1 and its relevance to patients treated with hemodialysis. Kidney Int 33 (Suppl 24): S21 - S26, 1988.

    Google Scholar 

  186. Bingel M, Lonnemann G, Shaldon S, Koch KM, Dinarello CA: Human interleukin-1 production during hemodialysis. Nephron 43: 161–163, 1986.

    Article  PubMed  CAS  Google Scholar 

  187. Haeffner-Cavaillon N, Cavaillon JM, Ciancioni C, Bade F, Delons S, Kazatchkine MD: In vivo induction of interleukin1 during hemodialysis. Kidney Int 35: 1212–1218, 1989.

    Article  PubMed  CAS  Google Scholar 

  188. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA: Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37: 85–93, 1990.

    Article  PubMed  CAS  Google Scholar 

  189. Pearson FC, Bohan JLW, Bruner G: Comparison of chemical analysis of hollow-fiber dialyzer extracts. J Artif Organs 8: 291–298, 1984.

    Article  CAS  Google Scholar 

  190. Harding GB, Pass T, Million C, Wright R, DeJarnette J, Klein E: Bacterial contamination of haemodialysis center water and dialysate: are current assays adequate? Artif Organs 13: 155–169, 1989.

    Article  PubMed  CAS  Google Scholar 

  191. Gould MJ: Performing the LAL gel-clot test in facilities. Nephrol News Issues 2911: 26–29, 1988.

    Google Scholar 

  192. Hakim RM, Friedrich RA, Lowrie EG: Formaldehyde kinetics in reused dialyzers. Kidney Int 28: 936–943, 1985.

    Article  PubMed  CAS  Google Scholar 

  193. Kaufman AM, Frinak S, Godmere RO, Levin NW: Clinical experience with heat sterilization for reprocessing dialyzers. ASAIO J 38: M338 - M340, 1992.

    Article  PubMed  CAS  Google Scholar 

  194. Vanholder R, NoensL, Eng RDS, Ringoior S: Development of anti-N-like antibodies during formaldehyde reuse in spite of adequate predialysis rinsing. Am J Kidney Dis 11: 477–480, 1988.

    CAS  Google Scholar 

  195. Pegues DA, Beck-Sague CM, Woollen SW, Reeenspan B, Burns SM, Bland LA, Ardeuno MJ, Favero MS, Mackow RC, Jarvis WR: Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzer and ACE inhibitor. Kidney Int 42: 1232–1237, 1992.

    Article  PubMed  CAS  Google Scholar 

  196. Schmitter L, Sweet S: Anaphylactic reactions with the addition of hypochlorite to reuse in patients maintained on reprocessed polysulfone hemodialyzers and ACE inhibitors. Paper presented at the annual meetings of the American Society of Artificial Internal Organs, New Orleans, April 1993.

    Google Scholar 

  197. U.S. Department of Health and Human Services, Food and Drug Administration: Tlk Paper T92–46, October 13, 1992.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, 37232-2372, USA

    Nuhad Ismail M.D., F.A.C.P. (Assistant Professor of Medicine), Bryan Becker M.D. & Raymond M. Hakim M.D., PH.D. (Professor of Medicine)

Authors
  1. Nuhad Ismail M.D., F.A.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bryan Becker M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raymond M. Hakim M.D., PH.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Wadi N. Suki M.D. Shaul G. Massry M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ismail, N., Becker, B., Hakim, R.M. (1998). Dialyzers, Dialysates, and Water Treatment. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_60

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6632-5_60

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6634-9

  • Online ISBN: 978-1-4757-6632-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation